Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Feb 27, 2024; 16(2): 382-395
Published online Feb 27, 2024. doi: 10.4240/wjgs.v16.i2.382
Published online Feb 27, 2024. doi: 10.4240/wjgs.v16.i2.382
Variables | Univariate analysis | Multivariate analysis | |||||
HR | 95%CI value | P value | HR | 95%CI | P value | ||
Gender | Male/female | 0.743 | 0.400-1.379 | 0.346 | |||
Age (yr) | 1.05 | 1.023-1.077 | < 0.001 | 1.067 | 1.035-1.099 | < 0.001 | |
Underlying disease | No/yes | 1.307 | 0.759-2.248 | 0.334 | |||
BMI | 0.98 | 0.915-1.048 | 0.553 | ||||
Tumor location | 0.264 | ||||||
Upper third | Ref | ||||||
Middle third | 0.434 | 0.117-1.604 | 0.211 | ||||
Lower third | 1.13 | 0.379-2.274 | 0.733 | ||||
Tumor dimensions (cm) | < 3/≥ 3 | 0.494 | 0.266-0.917 | 0.025 | 0.672 | 0.338-1.338 | 0.258 |
Differentiation | Moderate and poor/well | 0.047 | 0.000-11.342 | 0.275 | |||
TNM stage | 0.005 | 0.025 | |||||
I | Ref | Ref | |||||
II | 3.77 | 1.264-8.709 | 0.042 | 3.03 | 1.243-7.984 | 0.047 | |
III | 5.695 | 2.181-9.845 | 0.001 | 5.68 | 2.161-9.541 | 0.01 | |
Operation | Subtotal gastrectomy /total gastrectomy | 1.423 | 0.893-2.269 | 0.138 | |||
ASA | I-II/III-IV | 1.118 | 0.535-2.336 | 0.767 | |||
Perioperative transfusion | No/yes | 1.58 | 0.959-2.603 | 0.073 | |||
Blood loss (mL) | > 200 mL/≤ 200 mL | 1.763 | 1.109-2.803 | 0.016 | 1.498 | 0.914-2.458 | 0.109 |
Operation time (minutes) | 1.001 | 0.997-1.004 | 0.938 | ||||
CA199 (ng/mL) | Negative/positive | 1.347 | 0.780-2.327 | 0.286 | |||
CEA (ng/mL) | Negative/positive | 2.473 | 1.543-3.963 | < 0.001 | 1.266 | 0.76-2.108 | 0.365 |
Postoperative complication | No/yes | 4.787 | 2.846-8.052 | < 0.001 | 7.244 | 3.780-13.781 | < 0.001 |
Postoperative chemotherapy | No/yes | 2.929 | 1.543-5.562 | 0.001 | 1.298 | 0.649-2.597 | 0.461 |
P53 | Wild/Mutant | 0.728 | 0.455-1.165 | 0.186 | 0.392 | 0.231-0.663 | < 0.001 |
Ki-67 | 0.137 | 0.003 | |||||
0%-49% | Ref | Ref | |||||
50%-74% | 1.137 | 0.471-2.743 | 0.775 | 2.088 | 0.822-5.303 | 0.121 | |
75%-100% | 0.702 | 0.297-1.661 | 0.421 | 0.788 | 0.321-1.932 | 0.603 | |
Her-2 | Negative/positive | 0.321 | 0.079-1.310 | 0.113 | |||
Lymph node metastasis rate (%) | < 4.6%/≥ 4.6% | 5.943 | 2.845-12.414 | < 0.001 | 2.266 | 0.897-5.724 | 0.083 |
Enteral nutrition time | 1.023 | 0.965-1.186 | 0.443 | ||||
Length of hospitalization (days) | 1.032 | 0.995-1.070 | 0.092 | ||||
SIRI | ≤ 1.38/> 1.38 | 3.787 | 2.376-6.034 | < 0.001 | 2.696 | 1.579-4.404 | < 0.001 |
- Citation: Ren JY, Xu M, Niu XD, Ma SX, Jiao YJ, Wang D, Yu M, Cai H. Systemic inflammatory response index is a predictor of prognosis in gastric cancer patients: Retrospective cohort and meta-analysis. World J Gastrointest Surg 2024; 16(2): 382-395
- URL: https://www.wjgnet.com/1948-9366/full/v16/i2/382.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i2.382